학술논문

First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2020, 31 pS1173-pS1174, 2p. Supplement: 4
Subject
Language
English
ISSN
15698041